|
|
|||
Description:Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder. The disease is caused by mutations in the thymidine phosphorylase (TP) gene, TYMP. TP protein catalyzes phosphorolysis of thymidine to thymine and deoxyribose-1-phosphate, a salvage pathway involved in the maintenance of mitochondrial dNTP pools. Deficiency of TP causes the accumulation of thymidine. Both the enzyme activity in leukocytes and the elevated levels of thymidine in plasma can be measured (please see Thymidine Determination). The unbalanced mitochondrial deoxynucleotide pools result in mitochondrial DNA depletion, multiple deletions, or both in affected tissues. Clinical features of the disease usually occur between the second and the fifth decade of life. Gastrointestinal dysmotility is the most prominent clinical feature. Cerebral leukodystrophy is characteristic. Others include ptosis, progressive external ophthalmoplegia, cachexia, peripheral neuropathy, and myopathy. Reasons for Referral:
Testing Methodology:The exons and flanking intron regions of the TYMP gene are PCR amplified and sequenced. Specimen Requirements:Blood: EDTA (purple-top) tubes: Adult: 14 cc; Child: 6 cc; Infant: 2-3 cc Turnaround Time:Index: 3 weeks CPT Codes and Prices:Index:83904x8,
83898x4, 83912, 83891, 83894x2 Shipping InformationForms:>> Gene
Sequencing Requisition or Mitochondrial
Requisition - Mitochondrial Diagnostic Checklist is included References:1. Nishino
I, Spinazzola A, Hirano M. (1999) Thymidine phosphorylase gene mutations
in MNGIE, a human mitochondrial disorder. Science 283: 689-692. Test Codes:Index: 3060 |